Skip to main content

Plaque

0
Pipeline Programs
10
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

Solventum
SolventumMN - St. Paul
1 program
3M™ Oral RinseN/A1 trial
Active Trials
NCT03421145Completed200Est. Jan 2019
Takeda
TakedaTOKYO, Japan
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
Abbott
AbbottABBOTT PARK, IL
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
Philips
PhilipsNetherlands - Amsterdam
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
MSD
MSDIreland - Ballydine
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A1 trial
Active Trials
NCT00738725Completed7,687Est. Dec 2014
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk PopulationN/A
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Comparison ConditionN/A1 trial
Active Trials
NCT05321719Completed228Est. Apr 2024
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Listerine Zero MouthwashN/A1 trial
Active Trials
NCT02980497Completed370Est. Mar 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsComparison Condition
Solventum3M™ Oral Rinse
Johnson & JohnsonListerine Zero Mouthwash
Sharp TherapeuticsBioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

Clinical Trials (4)

Total enrollment: 8,485 patients across 4 trials

NCT05321719Oregon TherapeuticsComparison Condition

Multi-Media Parent-based Intervention to Promote Dental Hygiene Among Young Children: BeReady2Smile II

Start: Apr 2023Est. completion: Apr 2024228 patients
N/ACompleted
NCT03421145Solventum3M™ Oral Rinse

A Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

Start: Dec 2017Est. completion: Jan 2019200 patients
N/ACompleted
NCT02980497Johnson & JohnsonListerine Zero Mouthwash

Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study

Start: Sep 2013Est. completion: Mar 2014370 patients
N/ACompleted
NCT00738725Sharp TherapeuticsBioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

Start: Jan 2008Est. completion: Dec 20147,687 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

10 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.